Life sciences analytics for capitalizing on big data to foster global collaboration based on accurate clinical research information. Rapid clinical trial insights that let you accelerate promising programs or stop unproductive ones. And streamlined processes that get your products to market faster. SAS® is the de facto standard for clinical trials data analysis and reporting, and electronic submissions to regulatory authorities, such as the FDA. SAS delivers:
Support for CDISC. Standardize your clinical trials data and validate its adherence.
Risk-based monitoring. Optimize the scheduling of site visits and oversight by analyzing site and study data. Use advanced analytics to identify potential risks early enough to proactively address them.
Statistical analysis and reporting. Access and analyze clinical trials data to support clinical development decisions and submissions.
For more than 40 years, SAS has provided clinical trial data management and analysis solutions. We monitor life sciences research trends so we can provide innovative solutions that solve tomorrow's challenges. With SAS, you can promote fast, efficient information sharing, improve the validity and safety of clinical trials, and get better products to market faster. SAS also helps you:
Provide secure, global access to a centralized clinical knowledge base of consolidated, clean and standardized data from diverse sources.
Gain clinical insights quickly using core statistical analysis, data preparation, data visualization and advanced analytics – such as data and text mining, forecasting and optimization.
Easily and seamlessly implement industry standards such as those provided by CDISC, since relevant standards support is built into our core software.
Maximize revenue and reduce price erosion from launch through the remaining product life cycle with SAS’ advanced optimization and simulation analytics. SAS delivers proven global price intelligence solutions for:
Global launch sequencing. Discover optimal launch plans to navigate external reference pricing complexities. Leverage analytical insights to maximize revenue potential across all markets.
In-market price and revenue management. Quantify the global impact of pricing negotiation to make analytically sound strategic decisions throughout the remaining product life cycle.
When it comes to launching a new product in the life sciences industry, maximizing global revenue requires a complex balancing act between speed to market and a host of complex trade and pricing factors.
That’s what makes advanced analytics so critical in determining the most profitable launch sequence. Being able to address – and anticipate – all of those market dynamics with SAS® Launch Revenue Optimization could mean a difference of tens or even hundreds of millions of dollars in additional revenue.
Learn about advanced analytics for global price intelligence.
As the industry leader in analytics, SAS is uniquely positioned to help you standardize source data to IDMP-compliant data. With the intuitive visualization and reporting capabilities, you can seamlessly transform compliant data into true insights. SAS delivers:
Data standardization and data quality. Simplify how you standardize source data to IDMP-compliant data and feel confident that you’re in control of your data. SAS incorporates advanced master data managementcapabilities to integrate, standardize, and improve the quality of data originating from both structured and unstructured sources.
Efficient data remediation and governance across the organization. Reduce overall costs associated with data issues through more efficient workflow management and data remediation.
Natural language processing. Automate the extraction of required information from unstructured documents such as Summary of Product Characteristics (SmPCs). This once manual and time-consuming process is now easy using SAS® Contextual Analysis.
SAS delivers a single platform supporting all IDMP data standardization activities while providing added value beyond compliance. We also bring deep regulatory knowledge and industry experience to the development of an IDMP platform.
Choose experience and proven success. Data standardization is a core competency of SAS and is a key enabler for advanced business analytics. SAS has been a leader in the implementation of CDISC standards and uses the Observational Medical Outcomes Partnership common data model (OMOP) for real world intelligence.
Accelerate the implementation. SAS software’s IDMP logic, including Advanced IDMP text extraction, the IDMP Target data Model and Quality Knowledge Base enables you to get a jump start.
Value beyond compliance. While becoming IDMP-compliant is the primary objective, achieving this goal using SAS advanced master data management and analytical software delivers business value across the enterprise. SAS delivers a foundation to meet other business needs such as the General Data Protection Regulation, which will take effect in May 2018.
Identification of Medicinal Products, or IDMP, is the global regulatory standard for describing medicinal products. By ensuring that all stakeholders use the same language and vocabulary, IDMP is expected to improve patient safety globally.
Watch this overview video on what IDMP is about, when it will become effective, why you should consider SAS, how we can deliver and important next steps. Video produced May, 2017.
Learn how to become IDMP compliant and gain insights using SAS.
Controlled access to patient-level data for valid research purposes. The ability to analyze data from the clinical trials on which regulatory decisions are based. Our clinical trial data transparency solution delivers:
Secure data access. Grant authorized researchers access to de-identified patient-level clinical trials data through a secure clinical trials data repository.
Analytics for research. Enable researchers to analyze data using industry-leading analytics.
Flexible implementation options. Have the flexibility to support a company’s data transparency initiative or to provide shared access to clinical trials data from multiple companies.
Establish a secure clinical trials data repository. Give authorized researchers access to the data and powerful analytics. And rely on a company that life sciences organizations have trusted for more than three decades. As the market leader in clinical trials data transparency initiatives, SAS enables you to:
Give researchers access to the data they need. A secure clinical trials data repository ensures that authorized researchers have access to specified clinical trials data for their research purposes.
Empower researchers with embedded analytics. Because industry-leading analytic technologies are embedded into the system, researchers can derive greater insight from clinical trials data.
Take advantage of more than three decades of industry experience. SAS is globally recognized as the industry leader in business analytics and the de facto standard for clinical trial data analysis and reporting in life sciences. And we bring all that expertise to you.
When it comes to clinical trial data transparency, Charles Hugh-Jones, Chief Medical Officer at Sanofi North America, says, “There’s been huge progress in a very short period of time.” Find out why he describes the industry as being at a tipping point.
Real-world data from all relevant sources. A vast array of analytic tools for real-world evidence projects. And faster time to the insights you need for pipeline and commercialization decisions. SAS delivers:
Proven, powerful data management. Easily integrate real-world data from both internal and third-party sources – e.g., clinical, claims and consumer health care data.
Fast access to real-world evidence. Even nontechnical users can navigate, visualize and explore huge amounts of data quickly with an easy-to-use, point-and-click interface to powerful, in-memory analytics.
A complete analytical toolset. Choose from a wide range of analytic tools – from easy-to-use data visualization, to statistical programming, to more advanced data mining techniques – infused with cutting-edge, innovative algorithms that can help you extract evidence from real-world data sources to solve even your most complex problems.
Better assess the benefits, risks and cost-effectiveness of treatments based on actual patient outcomes and the total cost of care. Develop better therapies to improve patient care, provide evidence for payers and differentiate your brand in the health care market. And help ensure the best health outcomes and economic value for targeted patient populations. With SAS, you can:
Easily integrate real-world data from multiple sources and vendors. Spend less time preparing data and more time extracting valuable, real-world insights. Our leading data management capabilities ease the time-consuming process of gathering and preparing real-world data for analysis.
Go far beyond traditional query and reporting. Visually explore complex data sets of any size quickly and efficiently. Gain insights into key issues like brand strategy, treatment regiments, pricing, reimbursement and formulary access. And create meaningful reports that you can share via mobile devices.
Build an analytical foundation for real-world evidence. Give programmers, analysts, researchers and statisticians a comprehensive analytical toolset for building programs and models that can extract evidence from real-world data sources for pipeline and commercialization decisions.